Sort
11,323 grants matching “glioblastoma”
Signal Termination by PHLPP, PH domain Leucine-rich repeat Protein Phosphatase
$446,400Alexandra C. Newton · University Of California, San Diego · R01 · FY2014 · GM
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$446,391Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2014 · CA
A Bioprinted Volumetric Model of Vascularized Glioblastoma
$446,380Y. Shrike Zhang · Brigham And Women'S Hospital · R01 · FY2023 · CA
Activation of protein kinases by proline hydroxylation
$446,036Anna Lasorella · University Of Miami School Of Medicine · R01 · FY2025 · CA
Activation of protein kinases by proline hydroxylation
$446,036Anna Lasorella · University Of Miami School Of Medicine · R01 · FY2024 · CA
Connectivity mapping identified novel combination therapy for glioblastoma
$445,918Nicole Shonka · University Of Nebraska Medical Center · R01 · FY2022 · CA
Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.
$445,738Chunhai Charlie Hao · Indiana University Indianapolis · R01 · FY2024 · NS
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$445,712Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2021 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$445,712Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2020 · CA
Fast Targeted Spectroscopic Imaging for Brain Tumor Imaging at 3T and 7T
$445,706Hoby P Hetherington · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · EB
ENHANCEMENT OF BBB CROSSING OF AR DEGRADERS IN GBM
$445,500Bin Su · Cleveland State University · R15 · FY2025 · NS
Targeting Androgen Receptor-HSP27 Signaling in Glioblastoma
$445,500Bin Su · Cleveland State University · R15 · FY2021 · NS
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
$445,383Frederick F Lang · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
$445,383Frederick F Lang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
$445,335Jian Hu · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA
Hematopoietic Chemoprotection in Glioblastoma Patients
$445,303Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Signal Transduction Pathways in Glioblastoma
$445,200Arnab Chakravarti · Brigham And Women'S Hospital · R01 · FY2008 · CA
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2019 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2018 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2020 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2021 · OD
Characterizing glioma heterogeneity with novel multiplexed nanoscale imaging technologies
$445,000Fei Chen · Broad Institute, Inc. · DP5 · FY2017 · OD
The role of GPR133 in glioblastoma
$444,858Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2021 · NS
The role of GPR133 in glioblastoma
$444,858Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2022 · NS
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
$444,852Albert Hong-Jae Kim · Washington University · R01 · FY2023 · NS